Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS Coronavirus (SARS-CoV-2) Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04367168
What this trial is testing

Colchicine in Patients With Mild and Severe Coronavirus Disease

Who this might be right for
COVID
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 116
Large-scale testing (Phase 3)WithdrawnNCT04365231
What this trial is testing

Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial

Who this might be right for
COVID19
Hospital St. Joseph, Marseille, France
Not applicableStudy completedNCT04847596
What this trial is testing

Study to Assess Response to COVID-19 Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 25
Not applicableStudy completedNCT04379154
What this trial is testing

Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-COV-2 (COVID-19)

Who this might be right for
COVID-19
Hopital Foch 65
Not applicableStudy completedNCT05384886
What this trial is testing

Impact of New Variants and Vaccines on the Course of COVID-19

Who this might be right for
COVID-19
Izmir Katip Celebi University 15,967
Testing effectiveness (Phase 2)Study completedNCT04399356
What this trial is testing

Niclosamide for Mild to Moderate COVID-19

Who this might be right for
COVID-19
Tufts Medical Center 73
Not applicableStudy completedNCT04590222
What this trial is testing

Impact of a Monoamine Oxidase Inhibitor on the Phenotype of Blood Mononucleated Cells in Patients With COVID-19

Who this might be right for
SARS-CoV2 Infection
Assistance Publique - Hôpitaux de Paris 51
Large-scale testing (Phase 3)Not Yet RecruitingNCT06907251
What this trial is testing

Dapagliflozin for Long COVID Syndrome

Who this might be right for
COVID - 19Long COVID SyndromeSARS CoV-2
Ottawa Heart Institute Research Corporation 192
Testing effectiveness (Phase 2)Study completedNCT04313023
What this trial is testing

The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2

Who this might be right for
COVID-19
Pulmotect, Inc. 217
Post-approval studies (Phase 4)Study completedNCT04348370
What this trial is testing

BCG Vaccine for Health Care Workers as Defense Against COVID 19

Who this might be right for
CoronavirusCoronavirus InfectionCoronavirus as the Cause of Diseases Classified Elsewhere
Texas A&M University 659
Not applicableUnknownNCT04642703
What this trial is testing

Mortality in Patients With Severe COVID-19 Pneumonia Who Underwent Tracheostomy

Who this might be right for
Mechanical VentilationCovid19Tracheostomy
University of Chile 100
Post-approval studies (Phase 4)Ended earlyNCT04335786
What this trial is testing

Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease

Who this might be right for
Acute Respiratory Distress SyndromeSARS-CoV-2COVID+2 more
Radboud University Medical Center 23
Testing effectiveness (Phase 2)Study completedNCT05463354
What this trial is testing

Safety and Immunogenicity of Recombinant COVID-19 Vaccine (Sf9 Cell) as a Booster

Who this might be right for
COVID-19SARS-CoV-2 Infection
WestVac Biopharma Co., Ltd. 410
Not applicableStudy completedNCT04664023
What this trial is testing

Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution

Who this might be right for
Covid19
Poitiers University Hospital 130
Testing effectiveness (Phase 2)Study completedNCT04686773
What this trial is testing

Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention

Who this might be right for
COVID-19
R-Pharm 100
Not applicableStudy completedNCT05268679
What this trial is testing

Covid-19 Vaccine Response in Heart Transplant Recipients

Who this might be right for
Heart TransplantationCOVID-19 Virus InfectionCOVID-19 Vaccine
Assistance Publique - Hôpitaux de Paris 190
Not applicableStudy completedNCT04784403
What this trial is testing

SCREENING AND SEROEPIDEMIOLOGY OF SARS-CoV-2 INFECTION AT THE UNIVERSITY OF BARCELONA: A CROSS-SECTIONAL STUDY

Who this might be right for
SARS-CoV-2 Infection
Dr. Francisco Ciruela Alférez 3,356
Not applicableUnknownNCT04733170
What this trial is testing

Clinical Performance Evaluation of KnowNow SARS-CoV-2 Test for the Detection of COVID-19 Antigen

Who this might be right for
Covid19
Vatic Ltd. 600
Not applicableUnknownNCT05680896
What this trial is testing

SARS-CoV-2 Infection Among Healthcare Workers

Who this might be right for
COVID-19
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 600
Not applicableStudy completedNCT05171803
What this trial is testing

Investigating Immune Escape by SARS-CoV-2 Variants

Who this might be right for
COVID-19; Immunity
University of California, Los Angeles 38
Next Page